Ameritas Investment Partners’s Janux Therapeutics JANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $92.9K | Buy |
4,020
+820
| +26% | +$18.9K | ﹤0.01% | 1809 |
|
|
2025
Q1 | $86.4K | Buy |
3,200
+453
| +16% | +$12.2K | ﹤0.01% | 1803 |
|
|
2024
Q4 | $147K | Hold |
2,747
| – | – | ﹤0.01% | 1517 |
|
|
2024
Q3 | $125K | Hold |
2,747
| – | – | ﹤0.01% | 1650 |
|
|
2024
Q2 | $115K | Buy |
2,747
+1,041
| +61% | +$43.6K | ﹤0.01% | 1635 |
|
|
2024
Q1 | $64.2K | Hold |
1,706
| – | – | ﹤0.01% | 2003 |
|
|
2023
Q4 | $18.3K | Hold |
1,706
| – | – | ﹤0.01% | 2614 |
|
|
2023
Q3 | $17.2K | Buy |
1,706
+692
| +68% | +$6.98K | ﹤0.01% | 2607 |
|
|
2023
Q2 | $12K | Hold |
1,014
| – | – | ﹤0.01% | 2840 |
|
|
2023
Q1 | $12.3K | Hold |
1,014
| – | – | ﹤0.01% | 2654 |
|
|
2022
Q4 | $20.8K | Hold |
1,014
| – | – | ﹤0.01% | 2549 |
|
|
2022
Q3 | $13K | Hold |
1,014
| – | – | ﹤0.01% | 2709 |
|
|
2022
Q2 | $12K | Hold |
1,014
| – | – | ﹤0.01% | 2783 |
|
|
2022
Q1 | $15K | Hold |
1,014
| – | – | ﹤0.01% | 2665 |
|
|
2021
Q4 | $20K | Hold |
1,014
| – | – | ﹤0.01% | 2647 |
|
|
2021
Q3 | $22K | Buy |
+1,014
| New | +$22K | ﹤0.01% | 2648 |
|